{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 162 - Arun Swaminathan - CEO at Coya Therapeutics","slug":"episode-162-arun-swaminathan-ceo-at-coya-therapeutics","published_at":"2026-04-27T16:52:53+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-162-arun-swaminathan-ceo-at-coya-therapeutics","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-162---Arun-Swaminathan---CEO-at-Coya-Therapeutics-e3ihsl1","audio_url":"https://anchor.fm/s/f0076084/podcast/play/119124065/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-27%2F422973853-44100-2-b75d97a0ce737.mp3","summary":"In this episode of The BioHub Podcast by Avetix , Ben sits down with Dr. Arun Swaminathan, CEO of Coya Therapeutics, a clinical-stage biotechnology company developing therapies designed to enhance regulatory T cell function and target systemic inflammation and neuroinflammation. Arun brings more than 20 years of healthcare leadership experience across corporate strategy, business development, operations, and deal-making. At Coya, he is helping lead the company’s work in severe neurodegenerative diseases, including ALS, Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, with a focus on immunomodulatory and Treg-based therapeutic approaches. In this conversation, we discuss the evolving treatment landscape in neurodegeneration, the role of neuroinflammation in CNS drug development, what it takes to build and finance a clinical-stage biotech, and how combination therapeutic strategies could shape the next generation of disease-modifying treatments.","meta_description":"In this episode of The BioHub Podcast by Avetix , Ben sits down with Dr. Arun Swaminathan, CEO of Coya Therapeutics, a clinical-stage biotechnology compan…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1637,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-162-arun-swaminathan-ceo-at-coya-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-162-arun-swaminathan-ceo-at-coya-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}